In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Immunologist, James Allison
Nobel Prize in Medicine Awarded to Former MSK Immunologist, James Allison

The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012.
Memorial Sloan Kettering radiation oncologist Christopher Crane speaks with a patient.
Feature
Rays of Hope: Radiation Technique Controls Inoperable Liver Tumors

Learn how a new treatment approach using high-dose radiation has given hope to people with inoperable tumors.
Hodgkin lymphoma survivor Abby Wood
Feature
Abby’s Army: Hodgkin Lymphoma Survivor Cycles for a Cause

Hear from Abby Wood, a survivor of Hodgkin lymphoma, who is now giving back to MSK through fundraising with Cycle for Survival.
Fecal Transplants Proven to Restore Health-Promoting Bacteria

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs) can reestablish the health-promoting bacteria that are often damaged by intense antibiotic treatment in people who have stem cell or bone marrow transplants for blood cancer.
A nurse gives a girl a vaccination.
Q&A
HPV Vaccine and Cancer Risk: Frequently Asked Questions

Cancers linked to HPV are on the rise. But only a little over half of all adolescents in the U.S. got the full series of vaccinations. In this Q&A, Chrisann Kyi talks about why it's so important for young people to get vaccinated.
A woman considering birth control pills
Feature
Birth Control and Cancer Risk: 6 Things You Should Know

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.
Viviane Tabar and Lisa DeAngelis
Feature
What Really Matters in Treating Brain Cancer: An Interview with Two MSK Experts

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.
Different viewpoints of the STING pathway
In the Lab
Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments

Researchers are looking for ways to make cancer cells more visible to the immune system.
MSK pediatric oncologist Filemon Dela Cruz
Feature
The Treatments Changing Childhood Cancer: At Work with Filemon Dela Cruz

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.
MSK medical oncologist Anita Kumar
In the Clinic
Taking on Mantle Cell Lymphoma: MSK Leads Research into New Treatments

Learn about novel therapies emerging for the treatment of mantle cell lymphoma.